Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
80.50
+8.00 (11.03%)
At close: Dec 5, 2025, 4:00 PM EST
80.11
-0.39 (-0.48%)
After-hours: Dec 5, 2025, 7:43 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $598.07 million as of December 5, 2025. Its market cap has increased by 11,042.38% in one year.
Market Cap
598.07M
Enterprise Value
561.10M
1-Year Change
11,042.38%
Ranking
Category
Stock Price
$80.50
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $598.07M, an increase of 1,331.36%. That is a compound annual growth rate of 73.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 598.07M | 138.62% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |